Nome Químico: (1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol
Sorrisos: O[C@@H]1[C@@H](OCCOC)C[C@@H](N2C(N=C(SCCC)N=C3N[C@@H]4[C@@H](C5=CC=C(F)C(F)=C5)C4)=C3N=N2)[C@@H]1O
Inchi: InChI=1S/C21H34N6O8S/c1-2-7-36-21-23-19(22-10-8-12(34-5-3-28)17(32)15(10)30)14-20(24-21)27(26-25-14)11-9-13(35-6-4-29)18(33)16(11)31/h10-13,15-18,28-33H,2-9H2,1H3,(H,22,23,24)/t10-,11-,12+,13+,15+,16+,17-,18-/m1/s1
Estimation Of Ticagrelor In Commercial Dosage Form Using A Sensitive Validated RP-HPLC Method
By Madhuri, K.; Rao, Y. Srinivasa; Varaprasada, Rao K.; Deepthi, R.
From World Journal of Pharmaceutical Research (2021), 10(6), 1281-1292.
Development and validation of stability indicating RP-HPLC method for the estimation of Ticagrelor by forced degradation studies
By Dole, Manjusha; Kendre, Meenakshi; Wagh, Viplav
From World Journal of Pharmacy and Pharmaceutical Sciences (2019), 8(5), 711-724
Development of a validated HPLC-PDA method for stability indicating study of ticagrelor: a novel anti-platelet agent (P2Y12-ADP receptor blocker)
By Sulthana, Shabana; Anuradha, V.; Rao, Mandava V. Basaveswara
From International Journal of Pharmaceutical, Chemical and Biological Sciences (2017), 7(1), 36-42